Cognitive Exercise Therapy Approach Biopsychosocial Questionnaire (BETY-BQ) in Patient with Temporomandibular Disorders

NCT06186830 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-03-13

No results posted yet for this study

Summary

The aim of this study is to investigate the validity, reliability, and responsiveness of the Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire (BETY-BQ) in individuals with temporomandibular disorder. The following are alternative hypotheses of the study:

* BETY-BQ has significant convergence with the Patient Health Questionnaire-9 measuring depression.
* BETY-BQ has significant convergence with the Patient Health Questionnaire-15 measuring physical symptoms.
* BETY-BQ has significant convergence with the Generalized Anxiety Disorder-7 measuring anxiety.
* BETY-BQ has significant convergence with the Short Form-36 measuring quality of life.
* BETY-BQ has significant convergence with the Craniomandibular Pain and Disability Inventory measuring disability.
* BETY-BQ has significant convergence with the Mandibular Function Impairment Questionnaire measuring function.
* BETY-BQ has significant stability.
* BETY-BQ has significant internal consistency.

Conditions

  • Temporomandibular Disorder
  • Temporomandibular Joint Disorders
  • Temporomandibular Joint Dysfunction Syndrome

Interventions

OTHER

Validity and reliability analyses

Validity and reliability analyses will be performed using Cognitive Exercise Therapy Approach Biopsychosocial Questionnaire, Patient Health Questionnaire-9, Patient Health Questionnaire-15, Generalized Anxiety Disorder-7, Short Form-36, Craniomandibular Pain and Disability Inventory, and Mandibular Function Impairment Questionnaire.

Sponsors & Collaborators

  • Karabuk University

    collaborator OTHER
  • Hacettepe University

    lead OTHER

Principal Investigators

  • Harun Gençosmanoğlu, PT, MSc · Karabük University

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-17
Primary Completion
2024-07-15
Completion
2025-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06186830 on ClinicalTrials.gov